Literature DB >> 10745087

Morphine-related metabolites differentially activate adenylyl cyclase isozymes after acute and chronic administration.

K Eckhardt1, I Nevo, R Levy, G Mikus, M Eichelbaum, Z Vogel.   

Abstract

Morphine-3- and morphine-6-glucuronide are morphine's major metabolites. As morphine-6-glucuronide produces stronger analgesia than morphine, we investigated the effects of acute and chronic morphine glucuronides on adenylyl cyclase (AC) activity. Using COS-7 cells cotransfected with representatives of the nine cloned AC isozymes, we show that AC-I and V are inhibited by acute morphine and morphine-6-glucuronide, and undergo superactivation upon chronic exposure, while AC-II is stimulated by acute and inhibited by chronic treatment. Morphine-3-glucuronide had no effect. The weak opiate agonists codeine and dihydrocodeine are also addictive. These opiates, in contrast to their 3-O-demethylated metabolites morphine and dihydromorphine (formed by cytochrome P450 2D6), demonstrated neither acute inhibition nor chronic-induced superactivation. These results suggest that metabolites of morphine (morphine-6-glucuronide) and codeine/dihydrocodeine (morphine/dihydromorphine) may contribute to the development of opiate addiction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10745087     DOI: 10.1016/s0014-5793(00)01329-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Protein kinase A-independent responses to beta-adrenoceptor agonists.

Authors:  G Dent
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

2.  Sex-dependent influences of morphine and its metabolites on pain sensitivity in the rat.

Authors:  H H Doyle; A Z Murphy
Journal:  Physiol Behav       Date:  2017-12-01

3.  Differential Regulation of 6- and 7-Transmembrane Helix Variants of μ-Opioid Receptor in Response to Morphine Stimulation.

Authors:  Marino Convertino; Alexander Samoshkin; Chi T Viet; Josee Gauthier; Steven P Li Fraine; Reza Sharif-Naeini; Brian L Schmidt; William Maixner; Luda Diatchenko; Nikolay V Dokholyan
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.